Germany university is undertaking a Effects of Interventions and Lifestyle Modifications in Integrative Medicine and the Course of Infectious Respiratory Diseases study
Photo by Samantha Borges
Charite University, Berlin, Germany is starting a new clinical trial of Effects of Integrative Medicine on Infectious Respiratory Diseases.
The outbreak of the novel coronavirus SARS-CoV-2 caused a health emergency of international proportions when it was declared by the World Health Organization (WHO) in January 2020. Since then, the virus has spread internationally and the WHO has classified the outbreak as a pandemic. In the context of the increasing reporting of this pandemic and the increasing governmental measures to limit or slow down the spread of SARS-CoV-2 by all means, there is so far little scientific evidence for the effects of a healthy lifestyle on the disease. The aim of this study is to compare the potential of different, possibly protective lifestyles using the example of the COVID-19 pandemic. We will conduct an online survey with 3.000 participants using mobile website technology.
The study is advertised via a website, thus all interested people can participate in this survey.
The clinical trial started in December 2020 and will continue throughout December 2021.
The contacts and locations are the Charite University, Berlin, Germany.
The Charité – Universitätsmedizin Berlin is one of Europe's largest university hospitals, affiliated with Humboldt University and Free University Berlin. With numerous Collaborative Research Centres (CRC) of the Deutsche Forschungsgemeinschaft it is one of Germany's most research-intensive medical institutions. From 2012 to 2020, it was ranked by Focus as the best of over 1000 hospitals in Germany. In 2019 and 2020 Newsweek ranked the Charité as fifth best hospital in the world and best in Europe.
For more details: https://ichgcp.net/clinical-trials-registry/NCT04653727
